MLAIX
Price
$11.80
Change
+$0.05 (+0.43%)
Updated
Aug 21 closing price
Net Assets
11.82B
RGACX
Price
$84.57
Change
+$0.76 (+0.91%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

MLAIX vs RGACX

MLAIX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
MLAIX vs. RGACX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLAIX is a StrongBuy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 342B vs. MLAIX (11.8B). MLAIX (0.00) and RGACX (0.00) have matching dividends . MLAIX was incepted earlier than RGACX: MLAIX (21 years) vs RGACX (24 years). RGACX (0.93) is less costly to investors than MLAIX (0.70). MLAIX is a more actively managed with annual turnover of: 84.00 vs. RGACX (32.00). RGACX has a lower initial minimum investment than MLAIX: RGACX (250) vs MLAIX (1000000). RGACX annual gain was more profitable for investors over the last year : 4.90 vs. MLAIX (-9.02). RGACX return over 5 years is better than : 14.75 vs. MLAIX (-25.17).
MLAIXRGACXMLAIX / RGACX
Total Expense Ratio0.690.9374%
Annual Report Gross Expense Ratio0.700.9375%
Fund Existence21 years24 years-
Gain YTD3.0579.19333%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B342B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year-9.024.90-184%
Returns for 3 years16.0344.9536%
Returns for 5 years-25.1714.75-171%
Returns for 10 years18.0896.4419%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAPPX25.860.56
+2.21%
Morgan Stanley Inst Advantage A
NMGAX15.260.16
+1.06%
Neuberger Mid Cap Growth A
HSMBX47.180.38
+0.81%
Horizon Multi-Factor Small/Mid Cap Adv
JVARX42.710.23
+0.54%
JPMorgan Value Advantage R5
RYMGX62.120.31
+0.50%
Rydex S&P MidCap 400 Pure Growth A